大血管闭塞患者血管内治疗:尽管缺血半暗带极小仍可降低死亡率
该回顾性研究分析45例前循环大血管闭塞的急性缺血性卒中患者,CT灌注均显示无相关半暗带,比较血管内治疗与非血管内治疗的功能结局。血管内治疗组30天和90天mRS显著更低,死亡率显著降低,但良好功能结局(mRS 0-2)无显著差异。
要点
- CT灌注无相关半暗带的大血管闭塞患者,血管内治疗组30天和90天死亡率显著低于非血管内治疗组。
- 血管内治疗组30天和90天mRS值显著更低,但良好功能结局(mRS 0-2)两组无显著差异。
- 多变量回归显示血管内治疗与30天死亡风险降低相关(OR 0.091),与90天死亡风险降低相关(OR 0.134)。
核心结论
- CT灌注显示半暗带极小的急性缺血性卒中伴大血管闭塞患者,血管内治疗可能降低30天和90天死亡率,但未能证明良好功能结局获益。
研究设计与样本
- 回顾性分析45例发病6小时内入本科室的前循环大血管闭塞急性缺血性卒中患者,全部CT灌注显示无相关半暗带,按是否接受血管内治疗分组比较,采用多变量回归分析校正混杂。
临床应用与阅片要点
- 对于CT灌注显示无相关半暗带的前循环大血管闭塞患者,血管内治疗可能降低30天和90天死亡率,但良好功能结局未见显著改善。
局限性
- 样本量小且为高度选择的人群。
- 作者指出该研究为回顾性分析。
- 作者指出未能证明血管内治疗组30天和90天良好功能结局获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: In patients with acute ischemic stroke (AIS) caused by large vessel occlusion (LVO), endovascular treatment (EVT) is highly effective for emergency revascularization. However, data on functional outcome are lacking for patients, which show no or minimal mismatch between ischemic core and penumbra.
METHODS: Forty-five patients with AIS due to LVO of the anterior circulation were retrospectively analyzed within 6 h since onset when administered to our department. In all patients, there was no relevant penumbra according to CT perfusion (CTP). Functional outcome, defined by the modified Rankin Scale (mRS) at 30 and 90 days, was analyzed according to LVO treatment (EVT versus non-EVT). Confounding was addressed by multivariable regression analyses.
RESULTS: mRS values at 30 days (p = 0.002) and 90 days (p = 0.005) after AIS occurrence were significantly lower in patients who had received EVT. There was no significant difference regarding good functional outcome, as measured by mRS of 0-2 at 30 (p = 0.432) and 90 days, respectively (p = 0.186). Mortality was significantly reduced in patients undergoing EVT at 30-day (p < 0.001) and at 90-day follow-up (p = 0.003), respectively. Multivariable regression analyses revealed that EVT was associated with reduced mortality at 30 (OR 0.091; CI (0.013-0.612); p = 0.014) and 90 days (OR 0.134; CI (0.021-0.857); p = 0.034) after AIS.
CONCLUSIONS: Despite a small and highly selected patient collective, our study indicates that AIS patients with minimal penumbra in CTP might benefit from EVT in terms of reduced mortality at 30 and 90 days after AIS. However, in this group of patients, we could not prove favorable functional outcome at 30 and 90 days, despite receiving EVT.
引用
- Hoelter P, Schmidt M, Breuer L, et al. Endovascular treatment in patients with large vessel occlusion: reduced mortality despite minimal penumbra. Neuroradiology. 2019. PMID: 31463518. doi:10.1007/s00234-019-02280-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。